
This episode discusses HER2-positive gynecologic cancers and features insights from leading experts in the field.
Featuring perspectives from Dr Joyce F Liu, Dr David M O’Malley and Dr Brian M Slomovitz, moderated by Dr O’Malley, including the following topics: Introduction (0:00) Strategies to Identify Patients with HER2-Positive Gynecologic Cancers — Dr Liu (2:52) Available Data with and Practical Application of HER2-Targeted Therapy in Advanced Gynecologic Cancers — Dr Slomovitz (25:16) Identification and Management of Adverse Events with Trastuzumab Deruxtecan — Dr O’Malley (1:00:31) CME information and select publications
Host: Dr David M O’Malley
Guests: Dr Joyce F Liu, Dr Brian M Slomovitz
Organizations: Society of Gynecologic Oncology
Products: Trastuzumab Deruxtecan
Explore listener stats, chart rankings, contacts and more on the Gynecologic Oncology Update podcast page.